Obermatt
See Similar Stocks →

ALX Oncology Holdings

NSQ:ALXO · US00166B1052
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings17
Price/Book67
Dividend Yield—
Revenue Growth—
Profit Growth60
Capital Growth4
TSR 52w74
Leverage45
Liquidity44
Refinancing25
Combined—
Analyst Opinions26
Pro Holdings21
Opinion Changes50
Market Pulse42

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2015
Employees50
Websitealxoncology.com
ISINUS00166B1052
Last UpdateApr 2, 2026
Index & Theme
HematologyImmunologyOncology

Description

ALX Oncology Holdings Inc. operates as a clinical-stage immuno-oncology company. The company focuses on helping patients fight cancer by developing therapies that block the CD47 immune checkpoint and bridge the innate and adaptive immune systems. It…

Similar Stocks

The companies this stock is ranked against.

Compare ALX Oncology Holdings with its peers
Tharimmune
NAQ:THAR
—
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Adicet Bio
NAQ:ACET
26
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Bicara Therapeutics
NMQ:BCAX
43
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
CytomX Therapeutics
NSQ:CTMX
8
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Olema Pharmaceuticals
NSQ:OLMA
28
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Arbutus Biopharma
NSQ:ABUS
43
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →